Cargando…
The effect of α(1)-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study
Chronic obstructive pulmonary disease (COPD) is caused by α1-antitrypsin deficiency (AATD) genetic susceptibility and exacerbated by infection. The current pilot study aimed at studying the combined effect of AATD and bacterial loads on the efficacy of COPD conventional pharmacotherapy. Fifty-nine s...
Autores principales: | Hennawy, Marwa G., Elhosseiny, Noha M., Sultan, Hussein, Abdelfattah, Wael, Akl, Yousry, Sabry, Nirmeen A., Attia, Ahmed S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106446/ https://www.ncbi.nlm.nih.gov/pubmed/27857848 http://dx.doi.org/10.1016/j.jare.2016.05.002 |
Ejemplares similares
-
The parallel lives of alpha(1)-antitrypsin deficiency and pulmonary alveolar proteinosis
por: Trapnell, Bruce C, et al.
Publicado: (2013) -
Acinetobacter: an emerging pathogen with a versatile secretome
por: Elhosseiny, Noha M., et al.
Publicado: (2018) -
A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform
por: Nour El-Din, Hanzada T., et al.
Publicado: (2020) -
Alpha-1 Antitrypsin Deficiency in Iranian Patients with Chronic Obstructive Pulmonary Disease
por: Geramizadeh, Bita, et al.
Publicado: (2013) -
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial
por: Zarif, Bassem, et al.
Publicado: (2022)